Tatsuo Tsuri

644 total citations
16 papers, 544 citations indexed

About

Tatsuo Tsuri is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Tatsuo Tsuri has authored 16 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 9 papers in Pharmacology and 8 papers in Molecular Biology. Recurrent topics in Tatsuo Tsuri's work include Synthetic Organic Chemistry Methods (5 papers), Chemical Synthesis and Analysis (4 papers) and Inflammatory mediators and NSAID effects (4 papers). Tatsuo Tsuri is often cited by papers focused on Synthetic Organic Chemistry Methods (5 papers), Chemical Synthesis and Analysis (4 papers) and Inflammatory mediators and NSAID effects (4 papers). Tatsuo Tsuri collaborates with scholars based in Japan and United States. Tatsuo Tsuri's co-authors include Masanao Inagaki, Akinori Arimura, Kiyoshi Yasui, Zhen Yang, Alan Nadin, Eddy W. Yue, James E. Leresche, Susumu Kamata, Susumu Mitsumori and Mitsuaki Ohtani and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Tatsuo Tsuri

16 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tatsuo Tsuri Japan 13 403 165 164 80 43 16 544
S. Kodato Japan 14 282 0.7× 82 0.5× 257 1.6× 31 0.4× 42 1.0× 16 505
John C. Sih United States 13 381 0.9× 71 0.4× 234 1.4× 43 0.5× 20 0.5× 30 609
Annalina Lapucci Italy 16 446 1.1× 135 0.8× 307 1.9× 45 0.6× 9 0.2× 53 749
Shende Jiang China 15 430 1.1× 72 0.4× 265 1.6× 23 0.3× 46 1.1× 50 617
Tim Luker United Kingdom 18 606 1.5× 71 0.4× 166 1.0× 26 0.3× 45 1.0× 31 761
Philip M. Sher United States 8 466 1.2× 60 0.4× 139 0.8× 18 0.2× 31 0.7× 11 570
Tooru Kuroda Japan 15 621 1.5× 81 0.5× 261 1.6× 30 0.4× 66 1.5× 28 772
Girish K. Trivedi India 14 457 1.1× 92 0.6× 202 1.2× 33 0.4× 41 1.0× 67 624
David G. Loughhead United States 11 174 0.4× 82 0.5× 207 1.3× 60 0.8× 21 0.5× 13 423
Tomiki Hashiyama Japan 14 524 1.3× 67 0.4× 181 1.1× 49 0.6× 19 0.4× 32 649

Countries citing papers authored by Tatsuo Tsuri

Since Specialization
Citations

This map shows the geographic impact of Tatsuo Tsuri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatsuo Tsuri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatsuo Tsuri more than expected).

Fields of papers citing papers by Tatsuo Tsuri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tatsuo Tsuri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatsuo Tsuri. The network helps show where Tatsuo Tsuri may publish in the future.

Co-authorship network of co-authors of Tatsuo Tsuri

This figure shows the co-authorship network connecting the top 25 collaborators of Tatsuo Tsuri. A scholar is included among the top collaborators of Tatsuo Tsuri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tatsuo Tsuri. Tatsuo Tsuri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Mitsumori, Susumu, Tatsuo Tsuri, Tsunetoshi Honma, et al.. (2003). Synthesis and Biological Activity of Various Derivatives of a Novel Class of Potent, Selective, and Orally Active Prostaglandin D2Receptor Antagonists. 1. Bicyclo[2.2.1]heptane Derivatives. Journal of Medicinal Chemistry. 46(12). 2436–2445. 32 indexed citations
2.
Mitsumori, Susumu, Tatsuo Tsuri, Tsunetoshi Honma, et al.. (2003). Synthesis and Biological Activity of Various Derivatives of a Novel Class of Potent, Selective, and Orally Active Prostaglandin D2 Receptor Antagonists. 2. 6,6-Dimethylbicyclo[3.1.1]heptane Derivatives. Journal of Medicinal Chemistry. 46(12). 2446–2455. 53 indexed citations
3.
Inagaki, Masanao, Saichi Matsumoto, & Tatsuo Tsuri. (2003). Short Synthesis of tert-Butyl-Hydroxylated 3,5-Di-tert-butyl-4-hydroxybenzaldehyde:  Synthesis of tert-Butyl-Hydroxylated S-2474. The Journal of Organic Chemistry. 68(3). 1128–1131. 12 indexed citations
4.
Inagaki, Masanao, et al.. (2001). Highly E-Selective and Effective Synthesis of Antiarthritic Drug Candidate S-2474 Using Quinone Methide Derivatives. The Journal of Organic Chemistry. 67(1). 125–128. 12 indexed citations
5.
Inagaki, Masanao, Tatsuo Tsuri, Hirokuni Jyoyama, et al.. (2000). Novel Antiarthritic Agents with 1,2-Isothiazolidine-1,1-dioxide (γ-Sultam) Skeleton: Cytokine Suppressive Dual Inhibitors of Cyclooxygenase-2 and 5-Lipoxygenase. Journal of Medicinal Chemistry. 43(10). 2040–2048. 135 indexed citations
6.
Kawada, Kenji, Akinori Arimura, Tatsuo Tsuri, et al.. (1998). Total Synthesis of Terprenin, a Highly Potent and Novel Immunoglobulin E Antibody Suppressant. Angewandte Chemie International Edition. 37(7). 973–975. 37 indexed citations
7.
Kawada, Kenji, Akinori Arimura, Tatsuo Tsuri, et al.. (1998). Totalsynthese von Terprenin, einem hochwirksamen Immunglobulin-E-Suppressivum. Angewandte Chemie. 110(7). 1015–1017. 9 indexed citations
8.
Yonezawa, Shuji, Kenji Kawada, Tatsuo Tsuri, et al.. (1998). Total Synthesis of Terprenin, a Novel Immunosuppressive p-Terphenyl Derivative. The Journal of Organic Chemistry. 63(17). 5831–5837. 36 indexed citations
9.
Tsuri, Tatsuo, Tsunetoshi Honma, Toshihiko Okada, et al.. (1997). Bicyclo[2.2.1]heptane and 6,6-Dimethylbicyclo[3.1.1]heptane Derivatives:  Orally Active, Potent, and Selective Prostaglandin D2 Receptor Antagonists. Journal of Medicinal Chemistry. 40(22). 3504–3507. 28 indexed citations
10.
Nicolaou, K. C., Eddy W. Yue, Alan Nadin, et al.. (1995). Synthesis of Zaragozic Acid A/Squalestatin S1. Chemistry - A European Journal. 1(7). 467–494. 82 indexed citations
11.
Nicolaou, K. C., Alan Nadin, James E. Leresche, et al.. (1994). Synthesis of the First Fully Functionalized Core of the Zaragozic Acids/Squalestatins. Angewandte Chemie International Edition in English. 33(21). 2187–2190. 39 indexed citations
12.
Nicolaou, Kyriacos C., Alan Nadin, James E. Leresche, et al.. (1994). Synthese des ersten vollständig funktionalisierten Gerüstes der Saragossasäuren/Squalestatine. Angewandte Chemie. 106(21). 2309–2312. 19 indexed citations
13.
Tsuri, Tatsuo, et al.. (1992). A Novel Class of Platelet Activating Factor(PAF) Antagonists. II. Modification of the 2-Position of the Glycerol Backbone of PAF-Sulfonamide Isosteres.. Chemical and Pharmaceutical Bulletin. 40(1). 85–95. 3 indexed citations
14.
Tsuri, Tatsuo, et al.. (1992). A Novel Class of Platelet Activating Factor(PAF) Antagonists. I. Synthesis and Structure-Activity Studies on PAF-Sulfonamide Isosteres.. Chemical and Pharmaceutical Bulletin. 40(1). 75–84. 7 indexed citations
15.
Kamata, Susumu, et al.. (1990). Synthesis of thromboxane receptor antagonists with bicyclo[3.1.0]hexane ring systems. Journal of Medicinal Chemistry. 33(1). 229–239. 17 indexed citations
16.
Tsuri, Tatsuo & Susumu Kamata. (1985). An efficient and stereocontrolled synthesis of platelet activating factor from (s)-(−)-malic acid. Tetrahedron Letters. 26(42). 5195–5198. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026